Quick Answer
Eledon Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $22.81 million for the year ending 2025.
- Eledon Pharmaceuticals, Inc. showed an increase of +11.0% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Eledon Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 19, 2026.
- XBRL data for this metric is available from 2011 to 2025 (15 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 15 years of available data (2011 to 2025), Eledon Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 912.3%.
- Historical annual values: Fiscal year 2025: $22.81 million | Fiscal year 2024: $20.55 million | Fiscal year 2023: $4.61 million | Fiscal year 2022: $56.41 million | Fiscal year 2021: $84.83 million | Fiscal year 2020: $114.20 million | Fiscal year 2019: $8.79 million | Fiscal year 2018: $12.97 million | Fiscal year 2017: $17.23 million | Fiscal year 2016: $1.10 million | Fiscal year 2015: $24.02 million | Fiscal year 2014: $105.26 million | Fiscal year 2013: $31.75 million | Fiscal year 2012: $11.69 million | Fiscal year 2011: $2.25 million.
- Data sourced from SEC EDGAR public filings as of June 23, 2026.
Last verified: